This underlines the limitation of panel sequencing, which unlike WES or WGS, does not allow for future re-analysis of DNA to detect for mutations in leukodystrophy genes that are discovered after initial panel curation (in this case the CLCN2, AARS, CTSA, and RNF216 genes). The gene discussed is CLCN2; the disease is leukodystrophy.